Ocugen Inc (OCGN)

[Vector93]

Volume was low today, selling was lots of weak retail, which is good, but I also bad considering the upcoming events.

Retail is irrational and expected October 30 was going to be a definitive yes or no. When it was actually a “we’re still talking” it tanked anyway.

FDA guidelines say they will provide preliminary answers to questions 5 days before a Type C meeting to allow the company to revise or ask followup questions. Then the FDA will provide final answers within 30 days after the meeting (end of November ring a bell to anyone?)

This is all according to plan, but weak retail is expecting BLA approval by end of November.

THE FDA WILL NOT APPROVE ANYTHING END OF NOVEMBER.

The sooner retail sets realistic expectations, the better off we’ll be.

Q3 financials on November 8th. Expect scared, irrational, retail to dump on news of negative earnings, even though HSGX is pre-market and every pre-market bio ever is always negative earnings.

In preparation for the irrational reactions to upcoming events plan ahead. Sell before news, buy back in afterwards.


Truly good news will come through next year. Until then, expect more downward pressure.